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Histone lysine acetylation is central to epigenetic
control of gene transcription. Bromodomains of
chromosomal proteins function as acetyl-lysine
(Kac) binding domains. However, how bromodo-
mains recognize site-specific histones remains
unanswered. Here, we report three three-dimen-
sional solution structures of the bromodomains of
the human transcriptional coactivators CREB-bind-
ing protein (CBP) and p300/CBP-associated factor
(PCAF) bound to peptides derived from histone acet-
ylation sites at lysines 36 and 9 in H3, and lysine 20 in
H4. From structural and biochemical binding analy-
ses, we determine consensus histone recognition
by the bromodomains of PCAF and CBP, which rep-
resent two different subgroups of the bromodomain
family. Through bromodomain residues in the ZA
and BC loops, PCAF prefers acetylation sites with
a hydrophobic residue at (Kac+2) position and a
positively charged or aromatic residue at (Kac+3),
whereas CBP favors bulky hydrophobic residues at
(Kac+1) and (Kac+2), a positively charged residue
at (Kac-1), and an aromatic residue at (Kac-2).
INTRODUCTION
Chromatin, which packages all genomic DNA in eukaryotic cells,
functions as a fundamental regulator that governs global dy-
namic changes of gene expression and silencing (Nightingale
et al., 2006). Nucleosome functions as a building block of chro-
matin, consisting of DNA of 147 bp wrapped in two superhelical
turns around a histone octamer that is formed by an H3-H4 tet-
ramer and two H2A-H2B dimers. Nucleosome core particles are
linked by short stretches of DNA bound to the ‘‘linker’’ histones
H1 and H5 to form a nucleosomal filament that is folded into
higher-order structure of chromatin fiber. Site-specific histone
modifications, including acetylation, methylation, phosphoryla-
tion, ubiquitination, and sumoylation largely in the N- and
C-terminal residues, sets a dynamic platform for DNA-based
processes within the nucleus (Jenuwein and Allis, 2001; Turner,
2002). The extremely dense, versatile nature of histone modifica-
tions argues that histone signaling is far more complex in infor-
mation content than is cell-surface receptor signaling (SchreiberStructureand Bernstein, 2002; Seet et al., 2006). Despite its fundamental
importance to genomic stability and gene regulation, knowledge
of the detailed underlying molecular mechanisms of histone
signaling is lacking.
Histone lysine acetylation is highly dynamic and reversible and
plays an important role in directing chromatin remodeling and
gene transcription (Berger, 2002; Neely and Workman, 2002;
Turner, 1998). The functional role of acetylation in histone-
directed chromatin biology is highlighted by the discovery of
bromodomains as acetyl-lysine binding domains (Dhalluin
et al., 1999; Jacobson et al., 2000; Mujtaba et al., 2007) and is
reinforced by the function of the ‘‘Royal’’ family proteins of chro-
modomains and Tudor domains, MBT (malignant brain tumor)
domains, and more recently the PHD (plant homeo domain) fin-
gers, as methyl-lysine-binding domains (Bannister et al., 2001;
Lachner et al., 2001; Ruthenburg et al., 2007). Site- and state-
specific histone lysine acetylation and methylation have now
been recognized to serve as binding sites for effector proteins
(Fischle et al., 2003; Yap and Zhou, 2006). Such molecular inter-
actions have been postulated to constitute the readout of the so-
called epigenetic histone code that dictates distinct functions in
gene regulation in a sequential or combinatorial manner (Strahl
and Allis, 2000; Turner, 2002).
The functional importance in regulating chromatin biology
by bromodomain/acetyl-lysine interactions is underscored by
a large number of bromodomain-containing chromatin-associ-
ated proteins and histone acetyltransferases (HATs; >170 pro-
teins in humans; Jeanmougin et al., 1997). This fundamental
mechanism modulating protein-protein interactions by bromo-
domain/acetyl-lysine recognition argues that bromodomains
may contribute to site-specific histone acetylation, by tethering
nuclear HATs to specific chromosomal sites (Manning et al.,
2001; Travers, 1999), and to assembly of multiprotein remodel-
ing complexes SAGA and NuA4 (Brown et al., 2001; Sterner
et al., 1999) and SWI/SNF (Agalioti et al., 2002; Hassan et al.,
2002). This mechanism helps elucidate the reported phenotypes
linked to bromodomain mutation or deletion. For instance,
the bromodomain module is indispensable for the function of
GCN5 in yeast (Georgakopoulos et al., 1995; Syntichaki et al.,
2000). Deletion of a bromodomain in HBRM in the human SWI/
SNF complex causes decreased stability and loss of nuclear
localization (Muchardt et al., 1998; Muchardt and Yaniv, 1999).
Bromodomains of Saccharomyces cerevisiae Bdf1 are required
for sporulation and normal mitotic growth (Chua and Roeder,
1995). Bromodomain deletion in members of the RSC remodel-
ing complex causes a conditional lethal phenotype (Du et al.,16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved 643
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1999). Moreover, transgenic mice with lymphoid-restricted over-
expression of the double bromodomain-containing protein 2
(BRD2) develop splenic B cell lymphoma and leukemia (Green-
wald et al., 2004).
Despite its importance, our understanding of sequence-spe-
cific histone recognition by the bromodomain is limited. Thus
far, only a few structures of bromodomains bound to acetylated
peptides derived from biological binding partners have been
reported. These include the yeast GCN5 bromodomain/H4-
K16ac complex (Owen et al., 2000), human PCAF bromodomain
bound to the HIV Tat-K50ac peptide (Mujtaba et al., 2002), and
human CBP bromodomain bound to the p53-K382ac peptide
(Mujtaba et al., 2004). These complex structures, as well as the
free-form structures of other single or tandem bromodomains
from human TAFII250 (Jacobson et al., 2000), BPTF (Li et al.,
2006), BRD2 (Nakamura et al., 2007), and BRG1 (Shen et al.,
2007), and yeast Rsc4 (Vandemark et al., 2007), show that all
bromodomains adopt a conserved structural fold of a left-
handed, four-helix bundle, and two interhelical loops (i.e., the
ZA and BC loops) at one end of the bundle form a hydrophobic
pocket for acetyl-lysine binding. Although the bromodomain res-
idues important for acetyl-lysine binding are largely conserved,
sequence variations in the ZA and BC loops enable discrimina-
tion of different binding targets (Mujtaba et al., 2007). Sequence
variations and amino acid deletions in the flexible ZA and BC
loops suggest that these regions likely determine specificity of
ligand binding by interacting with residues flanking the Kac in
a target protein (Mujtaba et al., 2007). Thus, it is essential to
study bromodomains in the context of their biologically relevant
binding partners to understand their histone-binding selectivity.
In this study, we report three new, to our knowledge, three-
dimensional solution structures of the human transcriptional
coactivators PCAF and CBP bromodomains in complex with
histone peptides derived from known acetylation sites in H3 at
lysine 9 and lysine 36, and in H4 at lysine 20. Using combined
NMR-binding and structural analyses, we have defined consen-
sus histone recognition sequences for these two human bromo-
domains and their unifying features of histone recognition.
RESULTS AND DISCUSSION
Structures of the PCAF and CBP Bromodomains
Bound to Histone Peptides
To understand the molecular basis of site-specific histone rec-
ognition by bromodomains, we sought to conduct structural
analysis of the bromodomains from two prototypical coactivator
histone acetyltransferases PCAF and CBP. Because of their ma-
jor differences in the amino acid composition of the ZA loop that
comprises bromodomain’s ligand binding site, these two bromo-
domains represent two distinct subgroups of the large bromodo-
main family (Mujtaba et al., 2007). We chose lysine-acetylated
peptides derived from specific and nonspecific bromodomain
recognition sites in histones for the structural analysis—that is,
histone H3-K36ac (ATGGV-Kac-KPHRYK, where Kac is an
acetyl-lysine) and H4-K20ac (GGAKRHR-Kac-VLRDNIQ) as spe-
cific binding sites for the bromodomains of PCAF (Morris and
Moazed, 2007) and CBP (Garcia et al., 2007), respectively, and
H3-K9ac (ARTKQTAR-Kac-STGGKA) as a nonspecific binding644 Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rightssite for PCAF. We solved the three-dimensional solution struc-
tures of the PCAF bromodomain in complex with a H3-K36ac
peptide (Figures 1A, 1B, and 1C) and a H3-K9ac peptide (Figures
1D, 1E, and 1F), as well as the CBP bromodomain bound to a
H4-K20ac peptide (Figures 1G, 1H, and 1I).
The conformations of the bromodomain proteins in all three
complexes were well defined by the NMR data (Table 1). The
structures of the PCAF and CBP bromodomains bound to the
histone peptides adopt the conserved left-handed four-helix
bundle (helices aZ, aA, aB, and aC; Figures 1B, 1E, and 1H), but
the two proteins differ markedly in surface electrostatic potential
(Figures 1C, 1F, and 1I). The overall structure in each case is sim-
ilar to that of the free form (Dhalluin et al., 1999; Mujtaba et al.,
2004), but conformational differences were observed in the ZA
and BC loops, likely pertinent to accommodating peptide bind-
ing. This is supported by extensive NMR data, including changes
of chemical shifts and NOE (nuclear Overhauser effect) patterns
for the backbone amides, side-chain methyl groups, and aro-
matic rings of many protein residues. Because H3 and H4 resi-
dues flanking both sites of the acetyl-lysine are engaged in bro-
modomain recognition, the H3 or H4 peptides assume extended
conformations when bound to PCAF or CBP bromodomain.
However, because of the differences in the ways by which the
two histone H3 peptides interact with the PCAF bromodomain
(see below), the backbone orientations of the H3-K36ac and
the H3-K9ac peptides are antiparallel to each other, lying across
the hydrophobic binding site between the ZA and BC loops of the
PCAF bromodomain (compare Figure 1B with Figure 1E).
Acetyl-Lysine Recognition
The side chain of the acetyl-lysine of all three histone peptides
intercalates deep into the hydrophobic cavity of the bromodo-
mains. For instance, in the PCAF bromodomain, the acetylated
K36 in the H3-K36ac peptide interacts extensively with protein
residues Ala757 and Tyr760 on one side and Tyr802 and
Tyr809 on the other (Figure 2A), whereas the acetylated K9 in
the H3-K9ac peptide interacts with Val752, Ala757, and Tyr802
(Figure 2C). For the CBP bromodomain, the acetylated K20 in
the H4-K20ac peptide is immersed within a hydrophobic pocket
lined with Val1115, Leu1120, Ile1122, Tyr1125, Tyr1167, and
Val1174 (Figure 3A). In all three structures, the N-acetyl carbonyl
oxygen of the acetyl-lysine forms a hydrogen bond with the side-
chain amide hydrogen of a highly conserved asparagine (i.e.,
Asn803 in PCAF and Asn1168 in CBP) that serves as an anchor-
ing point of contact that stabilizes the acetyl-lysine in a deep cleft
of the protein. This explains that unacetylated histone peptides
do not bind to the bromodomain of PCAF or CBP.
Sequence-Specific Histone Recognition
Histone-binding selectivity is determined by bromodomain
recognition of histone residues flanking the acetyl-lysine. The
structures, which are supported by intermolecular NOEs in the
NMR spectra, reveal that the PCAF bromodomain recognizes
Pro(+2) and His(+3) at the H3-K36ac site (Figures 2A and 2B)
but only Ala(2) in H3-K9ac (Figure 2C), whereas the CBP bro-
modomain interacts with Val(+1), Leu(+2), Arg(1), and His(2)
residues of the H4-K20ac peptide (Figures 3A and 3B). In the
H3-K36ac peptide, Pro(+2) caps the opening of the hydrophobic
pocket by interacting with side chains of Ala757 and Pro758reserved
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Site-Specific Histone Recognition by BromodomainsFigure 1. 3D Structures of Bromodomains Bound to Acetylated Histone Peptides
The structures of the bromodomain/acetylated histone peptide complexes are shown in three different illustrations: stereoview of the backbone atoms (N, Ca,
and C0) of 25 superimposed NMR structures of the complexes (left); ribbons representation of the average minimized NMR structure of the complexes in a similar
orientation, prepared using Pymol (middle); and surface electrostatic potential representation of the protein with the peptide in a ball-and-stick depiction (right).
(A–C) The PCAF bromodomain/H3-K36ac complex.
(D–F) The PCAF bromodomain/H3-K9ac complex.
(G–I) The CBP bromodomain/H4-K20ac complex.Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved 645
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Site-Specific Histone Recognition by BromodomainsTable 1. Statistics of the NMR Structures of the Bromodomains Bound to Histone Peptides
PCAF/H3-K36ac PCAF/H3-K9ac CBP/H4-K20ac
NMR Distance and Dihedral Constraints
Distance constraints 3541 3009 2885
Intramolecular constraints 3441 2958 2847
Total NOE 3394 2911 2797
Intraresidue 1078 1060 1097
Interresidue 2316 1851 1700
Sequential (ji  jj = 1) 662 586 568
Medium range (ji  jj% 4) 774 630 662
Long range (ji  jj > 4) 880 635 470
Hydrogen bonds 47 47 50
Intermolecular constraints 100 51 38
Total dihedral angle restraints
Phi 70 70 72
Psi 70 70 72
Ramachandra Analysis, %a,b
Most favorable region 86.1 ± 1.6 85.0 ± 3.0 72.2 ± 2.1
Additional allowed region 12.3 ± 1.5 13.1 ± 2.6 22.2 ± 1.9
Generously allowed region 1.6 ± 0.6 1.2 ± 0.65 2.5 ± 1.7
Disallowed region 0.06 ± 0.24 0.7 ± 0.6 2.8 ± 1.1
Structure Statisticsa,b,c,d
Violations (mean ± SD)
Distance constraints (A˚) 0.077 ± 0.0049 0.080 ± 0.011 0.12 ± 0.03
Dihedral angle constraints () 1.05 ± 0.11 0.97 ± 0.068 0.77 ± 0.22
Max. distance constraint violation (A˚) 0.088 0.096 0.22
Max. dihedral angle constraints () 1.33 1.09 1.21
Deviations from idealized geometry
Bond lengths (A˚) 0.0093 ± 0.00014 0.0071 ± 0.00019 0.0064 ± 0.00026
Bond angles () 0.92 ± 0.016 0.78 ± 0.02 0.79 ± 0.027
Impropers () 0.77 ± 0.017 0.64 ± 0.019 0.71 ± 0.028
Average pair-wise root mean
square derivation (A˚)
Heavy 0.64 ± 0.066 0.83 ± 0.1 0.98 ± 0.13
Backbone 0.20 ± 0.035 0.34 ± 0.088 0.56 ± 0.15
a Based on 25 lowest energy-minimized structures.
b Protein include residues 725–827 for PCAF and residues 1087–1196 for CBP.
c None of these final structures exhibits NOE-derived distance restraint violations greater than 0.5 A˚ or dihedral angle restraint violations greater than 5.
d The Lennard-Jones Potential was not used during any refinement stage.(Figure 2A), This network of intermolecular interactions stabilizes
the bound peptide conformation and enables the acetyl-lysine
side chain to form a hydrogen bond with Asn803 in the deep cleft.
The H3-K36ac recognition by the PCAF BRD is further reinforced
by the aromatic ring of His(+3) that lies in a shallow pocket outside
of the BC loop and interacts with Tyr802 and Pro804 (Figure 2B).
For the H3-K9ac peptide, only the methyl group of Ala(2)
showed intermolecular NOEs to Ala757 and Pro758 of the pro-
tein (Figures 2C and 2D). Because PCAF bromodomain binding
to H3-K36ac involves much more extensive intermolecular inter-
actions than do those to H3-K9ac, the binding affinity of the for-
mer (dissociation constant [Kd] of 402 mM) is significantly higher
than that of the latter (Kd of 1051 mM; Figure 4B), as determined646 Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rights rusing saturation transfer difference (STD) NMR spectroscopy
(Meyer and Peters, 2003). The STD NMR is more suitable than
the conventional NMR method, on the basis of ligand-induced
chemical shift perturbations, for quantitative measurements
of protein interactions with affinity in the mM-to-mM range,
such as bromodomain/acetyl-lysine binding, because the former
can be performed with protein concentrations much lower than
the Kd. The STD-NMR results are consistent with the extent of
chemical shift perturbations of the bromodomain residues
upon the addition of the corresponding histone H3 peptide in
2D 15N-1H HSQC spectra (Figure 4C, red versus green signals).
Moreover, because Pro(+2) in H3-K36ac and Ala(2) in H3-K9ac
are resided on the opposite sides of the acetyl-lysine in theeserved
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Site-Specific Histone Recognition by Bromodomainshistone peptides, their interactions with the same hydrophobic
pocket of the bromodomain force two peptides to orient in anti-
parallel directions. Moreover, the opposite location of a large
positive amino acid with respect to the Kac—that is, Lys(+1) in
H3-K36ac versus Arg(1) in H3-K9ac—likely contributes to the
reverse orientations of the two peptides when bound to the pro-
tein, owing to interactions with the negative electrostatic poten-
tial surface at the entrance of the Kac-binding pocket (compare
Figure 1C with Figure 1F).
The H4-K20ac peptide binding to the CBP bromodomain
causes line-broadening of protein residues located at the pep-
tide-binding site, which is not the case for PCAF/H3 peptide
binding. This finding is consistent with the observation that
the binding affinity of the former (Kd of 218 mM, Figure 4B) is in
an intermediate exchange regime on the NMR time scale and
Figure 2. The Structural Basis of Histone
Recognition by the Bromodomains of
PCAF and GCN5
(A) and (C) Recognition of the acetyl-lysine of
H3-K36ac and H3-K9ac peptides by the human
PCAF bromodomain, respectively.
(B) and (D) Recognition of amino acid residues
flanking the acetyl-lysine of the H3-K36ac and
H3-K9ac peptides by the human PCAF bromodo-
main, respectively.
(E) and (F) Recognition of the acetyl-lysine and its
flanking residues of the H4-K16ac peptide by the
yeast GCN5 bromodomain (PDB code: 1E6I),
respectively.
(G) and (H) Recognition of the acetyl-lysine and its
flanking residues of the HIV-1 Tat-K50ac peptide
by the human PCAF bromodomain (PDB code:
1JM4), respectively.
In all four structures, side chains of protein or pep-
tide residues are color-coded by atom types—that
is, carbon (green for protein and yellow for pep-
tide), oxygen (red), and nitrogen (blue).
higher than that of the latter. As such,
fewer intermolecular NOEs were ob-
served and assigned unambiguously for
the CBP bromodomain/H4-K20ac com-
plex (Table 1). Nevertheless, an extended
conformation of the H4-K20ac peptide,
when bound to the CBP bromodomain,
was determined by intermolecular NOEs
assigned to histone residues flanking
both sides of the acetyl-lysine. Specifi-
cally, backbone atoms of Val(+1) and
Leu(+2) in the H4 peptide form pair-wise
interactions with those of the protein
residues Leu1120 and Leu1121, with the
main chains aligned in an antiparallel
fashion (Figure 3A). This intermolecular
interface is secured by interactions with
the side chains of Val(+1) and Leu(+2),
which point to opposite directions. These
two residues in the peptide further inter-
act with Arg1173 in aC of the protein.
H4-K20ac recognition is reinforced by
Arg(1) binding to Ile1122 and Tyr1167 and forms electrostatic
interactions with Asp1124 (Figure 3B). Additionally, His(2) con-
tributes to CBP bromodomain binding by interacting with
Tyr1167 and Arg1169 in the BC loop (Figure 3B). The latter res-
idues are not conserved in the bromodomain family, thus under-
scoring the selective nature of H4-K20ac recognition by the CBP
bromodomain.
Differences of Histone Binding Selectivity
by Bromodomains
To extend our understanding of bromodomain/histone binding
selectivity, we compared our structures to the available complex
structures of the PCAF bromodomain bound to HIV-1 Tat-K50ac
(SYGR-Kac-KRRQR; Mujtaba et al., 2002), the GCN5 bromodo-
main to H4-K16ac (A-Kac-RHRKILRNSIQGI) (Owen et al., 2000),Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved 647
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SRHK-Kac-LMFK; Mujtaba et al., 2004). To facilitate this struc-
tural analysis, we systematically measured the binding affinities
of the PCAF and CBP bromodomains to various lysine-acety-
lated peptides by STD-NMR (Figure 4B). Notably, the affinity of
individual bromodomain binding to acetyl-lysine in histones, as
shown in this study as well as those reported for the bromodo-
mains of Rsc4 (Vandemark et al., 2007) and BRG1 (Shen et al.,
2007), is generally much weaker than that of chromodomain
(Bernstein et al., 2006) or PHD finger (Li et al., 2006) binding to
methyl-lysine (Kd of 1–100 mM). These differences are likely not
just due to the use of different biophysical methods, because
we confirmed that the affinities of PCAF or CBP bromodomain
binding to respective HIV-1 Tat-K50ac or p53-K382ac peptide
measured by STD-NMR are comparable to those obtained in a
fluorescence polarization assay (Figure 4B). The latter is com-
monly used for measuring methyl-lysine binding by the chroma-
tin binding domains.
Our structural comparison confirms that the mode of acetyl-
lysine recognition is conserved in all three bromodomains. Con-
sistent with their high sequence identity of about 95%, the PCAF
and GCN5 bromodomains share a great deal of similarity in his-
tone binding. However, PCAF and CBP bromodomains exhibit
distinctive features in molecular recognition. As shown in the
PCAF bromodomain/H3 peptide complexes, the GCN5 bromo-
domain has a limited number of contacts with two flanking resi-
dues at (Kac+2) and (Kac+3) in the H4-K16ac peptide. Binding of
His(+2) by aromatic rings of Phe367 and Tyr406 of GCN5
(Figure 2E) is reminiscent of PCAF recognition of Pro(+2) in H3-
K36ac (Figure 2A), or Ala(2) in H3-K9ac (Figure 2C). Thus, it ap-
pears that recognition of flanking residues at (Kac+2) site and, to
a lesser extent, at (Kac+3) in the target histone sequence
anchors the conformation of the bound peptide, thereby rein-
forcing the acetyl-lysine binding in the hydrophobic pocket. Un-
like PCAF or GCN5, however, the CBP bromodomain recognizes
Figure 3. The Structural Basis of Histone
Recognition by the CBP Bromodomain
(A and B) Recognition of the acetyl-lysine and its
flanking residues in the H4-K20ac peptide by the
human CBP bromodomain, respectively.
(C and D) Recognition of the acetyl-lysine and its
flanking residues of the p53-K382ac peptide by
the human CBP bromodomain (PDB code:
1JSP), respectively.
Side chains of protein or peptide residues are
color-coded by atom types in the same scheme
as that in Figure 2.
the hydrophobic residue at (Kac+1) and
(Kac+2) sites in the target sequence.
Consistent with the structure of the
CBP/H4-K20ac complex, in the CBP
bromodomain/p53-K382ac complex,
Leu(+1) of the p53 peptide forms hydro-
phobic interactions with Val1115,
Ile1122, and Val1174 of the protein (Fig-
ures 3C and 3D). Notably, although this
major recognition site for one or two res-
idues flanking the acetyl-lysine is located similarly in the region
between the ZA and BC loops in PCAF and CBP bromodomains,
the two amino-acid insertions (including Leu1120 and Ile1121) in
the ZA loop in the CBP bromodomain distinguishes itself in its
histone-binding selectivity.
The second major binding site for the acetyl-lysine flanking
residues is located at the backside of the BC loop. As shown
in the GCN5 bromodomain/H4-K16ac complex structure, the
guanidinium group of Arg(+3) forms two hydrogen bonds to the
backbone carbonyl groups of Glu409 and Tyr414 (Figure 2F).
Similarly, the imidazole ring of His(+3) in H3-K36ac sits in the
pocket located similarly around the BC loop in the PCAF bromo-
domain and forms hydrogen bonds with backbone carbonyls
of Pro758, Tyr802, and Asn803 (Figure 2B). Moreover, similar
to His(2) in the H4-K20ac peptide, in the CBP bromodomain/
p53-K382ac complex, His(2) of p53-K382ac locates at the
back of the BC loop and interacts with Arg1169 and Tyr1167
of the CBP bromodomain (Mujtaba et al., 2004; Figure 3D).
Thus, His(2) in H4-K20ac or p53-K382ac peptide plays a func-
tional role in bromodomain recognition that is similar to that
of Arg(+3) in H4-K16ac or His(+3) in H3-K36ac. The residue of
(Kac-2) or (Kac+3) in the second interaction site likely works to-
gether with the acetyl-lysine in the conserved hydrophobic
pocket like a clamp that holds around the BC loop. Collectively,
these sequence-specific electrostatic and hydrophobic interac-
tions confer the target binding selectivity and affinity of a partic-
ular bromodomain.
The highly specific association of the PCAF bromodomain and
HIV-1 Tat at K50ac site is dependent on interactions with resi-
dues located at different positions flanking the acetyl-lysine.
For instance, Tyr(3) at the Tat-K50ac site shows intermolecular
NOEs with the PCAF residues Val763 and Glu801 that are re-
sided in the backside of the ZA and BC loops, which is analogous
to the recognition of His(+3) by the PCAF bromodomain, or Arg(+3)
by the CBP bromodomain (Figure 2H). Additionally, both Arg(+3)648 Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved
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of the PCAF bromodomain instead of carbonyls of the BC loop
(Figure 2G). Without these hydrogen-bonding interactions, the
PCAF bromodomain/Tat-K50ac binding is completely abolished
(Mujtaba et al., 2002). Note that Glu756 is not conserved and is
present in only a small subset of bromodomains, including
GCN5. Because of a lack of a structurally analogous Glu756, the
CBP bromodomain does not bind to HIV Tat-K50ac.
Conclusion
As the acetyl-lysine binding domain, the bromodomain, which is
present in a large number of chromatin-associated proteins and
histone acetyltransferases, plays a fundamental role in regula-
tion of chromatin remodeling and gene transcription (Mujtaba
et al., 2007). The solution structures of the PCAF and CBP bro-
modomains, in complex with lysine-acetylated histone H3 and
H4 peptides reported here, provide new insights into the molec-
ular basis of how these two prototypical bromodomains recog-
nize sequence-specific acetylyation sites in histones—a ques-
tion that remained unanswered until this study (Figure 4A). Our
study shows that for PCAF or PCAF-like bromodomains, the pre-
ferred acetyl-lysine-binding site in histones or cellular proteins
should have a hydrophobic residue at (Kac+2) and an aromatic
or positively charged residue at (Kac+3), whereas for the CBP
or CBP-like bromodomains, the consensus target sequence
should contain hydrophobic residues at (Kac+1) and (Kac+2)
and a positively charged residue at (Kac-1), as well as an aro-
matic residue at (Kac-2) (Figure 4B).
The new knowledge of histone-binding selectivity helps iden-
tify preferred histone recognition sites by bromodomain proteins.
For instance, we predicted that histone H3-K14ac (ARKSTGG-
Kac-APRKQLA) is likely a preferred site for the PCAF bromodo-
main, because it has a hydrophobic proline at (Kac+2) and a pos-
itively charged arginine at (Kac+3) (Figure 4B). In addition, a small
hydrophobic Ala(+1), and guanidinium group of Arg(+3) at this
site could enhance bromodomain binding by forming hydropho-
bic and electrostatic interactions, respectively. Indeed, the
H3-K14ac peptide binds to the PCAF bromodomain with an af-
finity better than that of H3-K36ac (Kd of 128 mM versus 402 mM),
as determined by STD-NMR (Figure 4B). This result is also sup-
ported by the chemical shift perturbations of the bromodomain
resonances in two-dimensional 15N-HSQC spectra induced by
the corresponding H3 peptides binding (Figure 4C). Moreover,
H4-K16ac (GLGKGGA-Kac-RHRKVLR) and H4-K20ac (GGAKR
HR-Kac-VLRDNIQ) sites both have an Arg(+3). Because the for-
mer has a histidine at (Kac+2) and the latter has a leucine, we pre-
dicted and confirmed by STD-NMR titration that bromodomain
binding to the H4-K16ac site is weaker than binding to the
H4-K20ac site (Kd of 365 mM versus 247 mM; Figure 4D). Similarly,
because the H3-K36ac site contains a nonoptimal sequence for
the CBP bromodomain, it binds much more weakly than does
the H4-K20ac to the CBP bromodomain (Kd of 218 mM versus
122 mM; Figure 4E).
The unifying features of site-specific histone recognition by
the bromodomains of PCAF and CBP emerging from the struc-
tures can be defined as three major contact points in the con-
served bromodomain fold, as illustrated in the structure of the
PCAF bromodomain/H3-K36ac peptide complex (Figure 4A).
First, acetyl-lysine is recognized by most, if not all, of the bromo-Structuredomains in a hydrophobic pocket embedded between the ZA
and BC loops at the bottom of the left-handed four-helix bundle
(Figure 4A, red region). The bromodomain residues engaged in
acetyl-lysine recognition are among the most highly conserved
amino acid residues in the large bromodomain family, which in-
cludes Tyr760, Tyr802, and Asn803 in PCAF. The latter forms
a hydrogen bond with the amide nitrogen of the acetyl-lysine.
Second, ZA and/or BC loop residues resided at the entrance of
the acetyl-lysine binding pocket interact, with one or two amino
acid residues at (Kac+/1) or (Kac+/2) adjacent to the acetyl-
lysine in the target protein (Figure 4A, blue region). These interac-
tions reinforce the binding of the acetyl-lysine of the target
sequence. Third, the additional ZA and BC loop residues that face
the backside of the bromodomain (i.e., opposite the aZ helix)
form hydrophobic and/or electrostatic interactions with target
sequence residues at (Kac+/3) or even further away from the
Kac (Figure 4A, green region). In such a way, the (Kac+3) residue
recognition by the bromodomain clamps on the BC loop to-
gether with the acetyl-lysine side chain that is bound inside the
hydrophobic pocket of the bromodomain.
Although many bromodomains use similar regions of the con-
served structural fold to interact with target proteins, sequence
variations in the highly flexible ZA and BC loops, with change,
addition, and deletion of amino acids, contribute to their distinct
histone-binding selectivity. As illustrated in our structural analy-
ses of the PCAF and CBP bromodomains, functional diversity
of bromodomains is likely achieved by evolutionary changes of
the structural features at the ligand-binding sites outside the
conserved scaffold. Because of low protein sequence similarity
in the ligand-binding sites, the unifying features of PCAF and
CBP bromodomains in histone recognition as defined here are
useful for identifying new biological ligands and assigning their
functions. Given the high degree of sequence variations and
structural dynamics of the ZA and BC loops, we expect that ad-
ditional modes of molecular recognition by bromodomains likely
exist, and their understanding requires new structural analysis of
these bromodomains in complex with their biological ligands
that may go beyond histones.
EXPERIMENTAL PROCEDURES
Sample Preparation
Expression and purification of the recombinant PCAF and CBP bromodomains
in poly-his tag form has been described elsewhere (Mujtaba et al., 2002, 2004).
The lysine-acetylated peptides were prepared on a MilliGen 9050 peptide syn-
thesizer (Perkin Elmer) using Fmoc/HBTU chemistry. Acetyl-lysine was incor-
porated using Fmoc-Kac with HBTU/DIPEA activation. N-terminal fluorescein
isocyanate-tagged peptides were prepared on solid-phase 4-formyl-3-me-
thoxy-phenyloxymethyl polystyrene resin (200–400 mesh) (Bachem) with Py-
BOP/HOBT as coupling reagents. Peptides were purified by reverse-phase
HPLC on a C18 column and were characterized by ESI-TOF mass spectrometry.
Protein Structure Determination by NMR Spectroscopy
NMR samples contained a protein/peptide complex of 0.5 mM in 100 mM
phosphate buffer (pH 6.5) that contains 5 mM perdeuterated DTT and
0.5 mM EDTA in H2O/
2H2O (9/1) or
2H2O. All NMR spectra were collected at
30C on NMR spectrometers of 800, 600, or 500 MHz. The 1H, 13C, and 15N
resonances of a protein of the complex were assigned by triple-resonance
NMR spectra collected with a 13C/15N-labeled and 75% deuterated protein
bound to an unlabeled peptide (Clore and Gronenborn, 1994). The distance re-
straints were obtained in three-dimensional 13C- or 15N-NOESY spectra.
Slowly exchanging amides, identified in two-dimensional 15N-HSQC spectra16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved 649
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Site-Specific Histone Recognition by BromodomainsFigure 4. Unifying Features of Histone Recognition by the Bromodomains of PCAF and CBP
(A) The unifying features of site-specific histone recognition by the PCAF and CBP bromodomains, as illustrated using the PCAF bromodomain/H3-K36ac com-
plex. Three main ligand contact sites for the recognition of the acetyl-lysine, residues at (Kac+/1) and/or (Kac+/2) sites, and residues at (Kac+/3) and beyond
are color coded in red, blue, and green, respectively.
(B) Sequences of major histone lysine-acetylation sites that are preferably recognized by the PCAF or CBP bromodomain along with dissociation constants (Kd)
of protein/peptide binding determined by STD NMR and fluorescent polarization binding assays as described in the Experimental Procedures. The amino acid
sequences of the two N-terminal fluorescinated peptides of HIV-1 Tat-K50ac and p53-K382ac are Fl-GGGG-SYGR-Kac-KRRQRC and Fl-(b-Ala)-RHK-Kac-
LMFK-NHC2H5, respectively.
(C) Comparison of the PCAF bromodomain binding to lysine-acetylated histone peptides as illustrated by two-dimensional 15N-1H HSQC spectra of the protein.
The protein amide resonances in the NMR spectra are color-coded as the following: PCAF bromodomain in free (black), or in the presence of a H3-K9ac (green),
H3-K14ac (red), and H3-K36ac (blue) peptide.
(D) NMR spectral comparison of the PCAF bromodomain in the free form (black), or in the presence of a H4-K16ac (blue), or H4-K20ac (red) peptide.
(E) NMR spectral comparison of the CBP bromodomain in the free form (black), or in the presence of an H3-K36ac (red) or H4-K20ac (blue) peptide.650 Structure 16, 643–652, April 2008 ª2008 Elsevier Ltd All rights reserved
Structure
Site-Specific Histone Recognition by Bromodomainsrecorded after a H2O buffer was changed to a
2H2O buffer, were used with
structures calculated with only NOE distance restraints to generate hydro-
gen-bond restraints for final structure calculations. The intermolecular NOEs
were detected in 13C-edited (F1),
13C/15N-filtered (F3), three-dimensional
NOESY spectrum.
Structure Calculations
Structures of the PCAF or CBP bromodomain/histone peptide complexes
were calculated with a distance geometry-simulated annealing protocol using
the X-PLOR program (Brunger et al., 1998), as described elsewhere (Mujtaba
et al., 2004). Manually assigned NOE-derived distance restraints were used to
calculate initial structures. ARIA (Nilges and O’Donoghue, 1998) assigned dis-
tance restraints agree with structures calculated using only the manually deter-
mined NOE distance restraints. Ramachandran plot analysis of the final struc-
tures was performed with Procheck-NMR program (Laskowski et al., 1996).
Protein/Peptide Binding by Saturation Transfer Difference NMR
Affinity of bromodomain binding to lysine-acetylated peptides was measured
using STD-NMR spectroscopy (Meyer and Peters, 2003). The NMR pulse
program uses the WATERGATE scheme for water suppression and a presatu-
ration by alternating on and off resonance frequencies after each scan to
eliminate in-homogeneity artifacts in signal difference accumulations. On res-
onance irradiation was set on frequency at 400 Hz (0.8 ppm) for PCAF sig-
nal of Pro747 HG2 and 822 Hz (1.6 ppm) for CBP signal of Val1157 HG21,
whereas off resonance irradiation was tuned at 22,253 Hz (44 ppm) where no
protein or peptide signals were present. The NMR resonance of the acetyl
methyl group (1.90 ppm) was used to derive binding disassociation (Kd) of
all peptides. Selective saturation of the protein was achieved by a train of
Gauss-shaped pulses of 49 ms length, truncated at 1%, and separated by a
1 ms delay. Sixty selective pulses were applied with a total saturation of 3 s
and a recovery delay of 2 s. A total number of scans was 256–10,000. Protein
concentrations (15 mM) were determined by UV absorbance, whereas peptide
concentrations were calibrated in 1D-NMR of DMSO (0.2 mM) in the same
NMR buffer. The dissociation constants were determined by using nonlinear
regression analysis with SigmaPlot (Version 10.01).
Fluorescent Polarization
Fluorescent polarization was performed for PCAF and CBP bromodomains’
binding to two fluorescinated peptides of HIV-1 Tat-K50ac (Fl-GGGG-SYGR-
Kac-KRRQRC) and p53-K382ac (Fl-(b-Ala)-RHK-Kac-LMFK-NHC2H5), re-
spectively. Protein concentrations were determined by absorbance spectros-
copy using calculated molar extinction coefficients (3280 = 25,440 M
1 cm1
and 17,420 M1 cm1 for CBP and PCAF, respectively). Peptide concentrations
were determined using absorbance spectroscopy (3494 = 68,000 M
1 cm1
for the fluorescinated peptides). Fluorescent polarization assay was performed
in polypropylene 96-well plates (Costar) with 10 nM fluorescein-labeled pep-
tide and varying concentrations of a protein in 25 mM Tris-buffer (pH 7.4),
100 mM NaCl, and 1 mM Imidazol in 100 ml. Measurements were obtained after
10 min incubation of the peptide and the protein at 25C using a fluorescence
polarization reader (Tecan). Dissociation constants were determined as a one-
site model (Roehrl et al., 2004) by fitting the binding data with SigmaPlot to the
following equation: Fb = {(Kd + P + R)  [(Kd + P + R)2  (43 P3 R)]1/2}/(23 P),
where Fb is fraction of bound labeled ligand, Kd = dissociation constant, R =
total protein concentration, and P = total fluorescent-peptide concentration.
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